Stock Information
Trevi Therapeutics Inc (TRVI)
Ticker Symbol: TRVI
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,531.07 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.3207
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -25.49%
Latest News
-
Transcript : Trevi Therapeutics, Inc. - Analyst/Investor Day
Thu, May 7, 2026 1:20 PM
-
HC Wainwright & Co. Reiterates Buy on Trevi Therapeutics, Maintains $21 Price Target
Wed, May 6, 2026 8:09 AM
-
Needham Maintains Buy on Trevi Therapeutics, Lowers Price Target to $23
Wed, May 6, 2026 7:19 AM
-
Trevi Therapeutics, Inc. (TRVI) Q1 2026 Earnings Call Transcript
Wed, May 6, 2026 6:01 AM
-
Transcript : Trevi Therapeutics, Inc., Q1 2026 Earnings Call, May 05, 2026
Wed, May 6, 2026 5:50 AM
-
Trevi Therapeutics Q1 2026 Earnings Call Transcript
Tue, May 5, 2026 5:20 PM
-
Trevi Therapeutics Q1 EPS $(0.09) Misses $(0.07) Estimate
Tue, May 5, 2026 4:11 PM
-
Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
Tue, May 5, 2026 4:07 PM
-
Earnings Scheduled For May 5, 2026
Tue, May 5, 2026 7:12 AM
Key Financials
Financial data not available
